Jared Roberts, MD
Obstetrics & Gynecology · Birmingham, ALNPI 1164659389
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.5% of the total across 156 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 33 manufacturers, the largest accounting for just 16.1% — the pattern of someone who eats at a lot of different presentations.
Across 156 payments — averaging $16.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$411
- Astellas Pharma US Inc$268
- Sumitomo Pharma America, Inc.$236
- Amgen$213
- Coopersurgical, Inc.$177
- Hologic Sales And Service, LLC$141
- plus $1K from 27 others
What the payments were for
- Food & beverage$2,543100%
- Education$120%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 27 | $411 |
| Astellas Pharma US Inc | 17 | $268 |
| Sumitomo Pharma America, Inc. | 17 | $236 |
| Amgen | 13 | $213 |
| Coopersurgical, Inc. | 6 | $177 |
| Hologic Sales And Service, LLC | 10 | $141 |
| Mayne Pharma Commercial LLC | 13 | $118 |
| Exeltis, USA Inc. | 5 | $96 |
| Bayer | 6 | $93 |
| Aspira Women's Health Inc | 1 | $92 |
| Baxter Healthcare | 1 | $86 |
| Organon | 4 | $75 |
| Mylan Pharmaceuticals Inc. | 5 | $70 |
| Pfizer | 4 | $69 |
| Shield Therapeutics Inc | 3 | $48 |
| Evofem Biosciences, Inc. | 2 | $32 |
| Agile Therapeutics, Inc. | 2 | $31 |
| Boston Scientific | 2 | $29 |
| Merck | 2 | $29 |
| Tempus AI, Inc | 1 | $26 |
| Duchesnay USA Incorporated | 2 | $24 |
| Novo Nordisk | 2 | $22 |
| Roche Diagnostics Corporation | 1 | $21 |
| AstraZeneca | 1 | $19 |
| Lupin Inc. | 1 | $17 |
| Minerva Surgical, Inc | 1 | $16 |
| Millicent US Inc | 1 | $16 |
| Sage Therapeutics, LLC | 1 | $16 |
| Johnson & Johnson | 1 | $14 |
| DUSA Pharmaceuticals, Inc. | 1 | $13 |
| BD | 1 | $13 |
| AMAG Pharmaceuticals, Inc. | 1 | $12 |
| Nalpropion Pharmaceuticals LLC | 1 | $12 |
How this compares
$2,555 in reported general payments places this provider in the 65th percentile of 537 obstetrics & gynecology providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 31 | $1,500 |
| Lorazepam | 11 | $24 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Birmingham
- Theodore TsaltasBirmingham$853K
- Tomeka RobertsBirmingham$44K
- Percy HudsonBirmingham$29K
- Heidi StraughnBirmingham$29K
- William HudsonBirmingham$13K
- William JohnsonBirmingham$10K
- Cynthia BrownBirmingham$10K
- Loretta PrestonBirmingham$10K
- Laura Lee JoinerBirmingham$9K
- Victoria WheelerBirmingham$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.